NRF2 metagene signature is a novel prognostic biomarker in colorectal cancer (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.2.13614/v1

Publication URI: http://dx.doi.org/10.21203/rs.2.13614/v1

Type: Preprint